hagocytosis is a well understood process whereby pathogens and cell debris are removed from within the body, and it is an important homeostatic mechanism in health and disease. What is less commonly discussed is the process of "efferocytosis." This term, derived from the Latin prefix effero-, meaning "to take away, to carry to the grave, or to bury" (1), is a more nuanced mechanism of phagocytosis, which focuses on the clearance of apoptotic cells by neutrophils and macrophages.
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Efferocytosis has been studied in cancer and in a more limited capacity in atherosclerosis. In a recent study in Nature, Kojima et al. (2) described the role of CD47 in the development of atherosclerosis and proposed that anti-CD47 antibodies may represent a novel therapeutic strategy for treating coronary artery disease by promoting efferocytosis.
In this paper (2), CD47 was found to be increased in the atherosclerotic regions of human coronary and carotid arteries. Of note, the increase in CD47 was localized to the necrotic core of the plaques and was up-regulated to a greater extent in people with a history of stroke or transient ischemic attack, reported that he has no relationships relevant to the contents of this paper to disclose.
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